152 related articles for article (PubMed ID: 12193584)
1. Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice.
Filvaroff EH; Guillet S; Zlot C; Bao M; Ingle G; Steinmetz H; Hoeffel J; Bunting S; Ross J; Carano RA; Powell-Braxton L; Wagner GF; Eckert R; Gerritsen ME; French DM
Endocrinology; 2002 Sep; 143(9):3681-90. PubMed ID: 12193584
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice.
Varghese R; Gagliardi AD; Bialek PE; Yee SP; Wagner GF; Dimattia GE
Endocrinology; 2002 Mar; 143(3):868-76. PubMed ID: 11861508
[TBL] [Abstract][Full Text] [Related]
3. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs.
Gagliardi AD; Kuo EY; Raulic S; Wagner GF; DiMattia GE
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E92-105. PubMed ID: 15367391
[TBL] [Abstract][Full Text] [Related]
4. Stanniocalcin 1 as a pleiotropic factor in mammals.
Yoshiko Y; Aubin JE
Peptides; 2004 Oct; 25(10):1663-9. PubMed ID: 15476933
[TBL] [Abstract][Full Text] [Related]
5. Evidence for stanniocalcin gene expression in mammalian bone.
Yoshiko Y; Son A; Maeda S; Igarashi A; Takano S; Hu J; Maeda N
Endocrinology; 1999 Apr; 140(4):1869-74. PubMed ID: 10098526
[TBL] [Abstract][Full Text] [Related]
6. Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouse.
Stasko SE; Wagner GF
J Endocrinol; 2001 Nov; 171(2):237-48. PubMed ID: 11691643
[TBL] [Abstract][Full Text] [Related]
7. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
Yamazaki H; Sasaki T
J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
[TBL] [Abstract][Full Text] [Related]
8. Post-natal ontogeny of stanniocalcin gene expression in rodent kidney and regulation by dietary calcium and phosphate.
Deol H; Stasko SE; De Niu P; James KA; Wagner GF
Kidney Int; 2001 Dec; 60(6):2142-52. PubMed ID: 11737588
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
10. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses.
Amling M; Priemel M; Holzmann T; Chapin K; Rueger JM; Baron R; Demay MB
Endocrinology; 1999 Nov; 140(11):4982-7. PubMed ID: 10537122
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
Dai XM; Zong XH; Akhter MP; Stanley ER
J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
[TBL] [Abstract][Full Text] [Related]
12. The distribution of stanniocalcin 1 protein in fetal mouse tissues suggests a role in bone and muscle development.
Jiang WQ; Chang AC; Satoh M; Furuichi Y; Tam PP; Reddel RR
J Endocrinol; 2000 May; 165(2):457-66. PubMed ID: 10810309
[TBL] [Abstract][Full Text] [Related]
13. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
14. Avian stanniocalcin-2 is expressed in developing striated muscle and joints.
Mittapalli VR; Pröls F; Huang R; Christ B; Scaal M
Anat Embryol (Berl); 2006 Oct; 211(5):519-23. PubMed ID: 16718479
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
Larsson T; Marsell R; Schipani E; Ohlsson C; Ljunggren O; Tenenhouse HS; Jüppner H; Jonsson KB
Endocrinology; 2004 Jul; 145(7):3087-94. PubMed ID: 14988389
[TBL] [Abstract][Full Text] [Related]
16. Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals.
Misof BM; Roschger P; Tesch W; Baldock PA; Valenta A; Messmer P; Eisman JA; Boskey AL; Gardiner EM; Fratzl P; Klaushofer K
Calcif Tissue Int; 2003 Sep; 73(3):251-7. PubMed ID: 14667138
[TBL] [Abstract][Full Text] [Related]
17. Type XIII collagen strongly affects bone formation in transgenic mice.
Ylönen R; Kyrönlahti T; Sund M; Ilves M; Lehenkari P; Tuukkanen J; Pihlajaniemi T
J Bone Miner Res; 2005 Aug; 20(8):1381-93. PubMed ID: 16007336
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling.
Westberg JA; Serlachius M; Lankila P; Penkowa M; Hidalgo J; Andersson LC
Stroke; 2007 Mar; 38(3):1025-30. PubMed ID: 17272771
[TBL] [Abstract][Full Text] [Related]
19. Cartilage abnormalities are associated with abnormal Phex expression and with altered matrix protein and MMP-9 localization in Hyp mice.
Miao D; Bai X; Panda DK; Karaplis AC; Goltzman D; McKee MD
Bone; 2004 Apr; 34(4):638-47. PubMed ID: 15050894
[TBL] [Abstract][Full Text] [Related]
20. Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1.
Roschger P; Matsuo K; Misof BM; Tesch W; Jochum W; Wagner EF; Fratzl P; Klaushofer K
Bone; 2004 May; 34(5):776-82. PubMed ID: 15121008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
